BACKGROUND: The glycoprotein (gp) 96 links the adaptive with the innate immune system. It is a chaperone with a binding domain for peptides generated by proteasomal degradation. During cellular stress, peptide loaded gp96 can be released and presented to T cells by antigen presenting cells (APCs). METHODS: mRNAs from in vitro differentiated macrophages (iv mac) and normal intestinal macrophages (IMACs) were compared by subtractive hybridisation and Affymetrix GeneChip analysis. Differentiation induced expression of gp96 was investigated in the multicellular spheroid (MCS) model. In vivo gp96 protein expression was detected by double labelling immunohistochemistry of human colon and in the CD4+ CD62L+ T cell transfer mouse model. RESULTS: Five of 76 clones obtained by subtractive hybridisation revealed >99% sequence homology to gp96. Affymetrix GeneChip analysis confirmed induction of gp96 in IMACs. Gp96 mRNA was detected in IMACs from normal and intestinal bowel disease mucosa. Induction of gp96 protein was observed after seven days in the MCS model of IMAC differentiation. Immunohistochemistry confirmed the presence of gp96 protein in IMACs in normal mucosa as well as in mucosa from patients with ulcerative colitis and diverticulitis. In mucosa from Crohn's disease (CD) patients, gp96 protein was not detectable. In the CD4+ CD62L+ T cell transfer mouse model, gp96 was verifiable in non-activated IMACs. CONCLUSION: Gp96 is induced during differentiation of normal IMACs but is not detected in IMACs in CD mucosa. As gp96 has been described as having a role in tolerance induction, this may be relevant for loss of tolerance against luminal bacteria found in CD patients.
BACKGROUND: The glycoprotein (gp) 96 links the adaptive with the innate immune system. It is a chaperone with a binding domain for peptides generated by proteasomal degradation. During cellular stress, peptide loaded gp96 can be released and presented to T cells by antigen presenting cells (APCs). METHODS: mRNAs from in vitro differentiated macrophages (iv mac) and normal intestinal macrophages (IMACs) were compared by subtractive hybridisation and Affymetrix GeneChip analysis. Differentiation induced expression of gp96 was investigated in the multicellular spheroid (MCS) model. In vivo gp96 protein expression was detected by double labelling immunohistochemistry of human colon and in the CD4+ CD62L+ T cell transfer mouse model. RESULTS: Five of 76 clones obtained by subtractive hybridisation revealed >99% sequence homology to gp96. Affymetrix GeneChip analysis confirmed induction of gp96 in IMACs. Gp96 mRNA was detected in IMACs from normal and intestinal bowel disease mucosa. Induction of gp96 protein was observed after seven days in the MCS model of IMAC differentiation. Immunohistochemistry confirmed the presence of gp96 protein in IMACs in normal mucosa as well as in mucosa from patients with ulcerative colitis and diverticulitis. In mucosa from Crohn's disease (CD) patients, gp96 protein was not detectable. In the CD4+ CD62L+ T cell transfer mouse model, gp96 was verifiable in non-activated IMACs. CONCLUSION:Gp96 is induced during differentiation of normal IMACs but is not detected in IMACs in CD mucosa. As gp96 has been described as having a role in tolerance induction, this may be relevant for loss of tolerance against luminal bacteria found in CDpatients.
Authors: M Hausmann; T Spöttl; T Andus; G Rothe; W Falk; J Schölmerich; H Herfarth; G Rogler Journal: Clin Exp Immunol Date: 2001-07 Impact factor: 4.330
Authors: T Spöttl; M Hausmann; M Kreutz; A Peuker; D Vogl; J Schölmerich; W Falk; R Andreesen; T Andus; H Herfarth; G Rogler Journal: J Leukoc Biol Date: 2001-08 Impact factor: 4.962
Authors: G Rogler; M Hausmann; T Spöttl; D Vogl; E Aschenbrenner; T Andus; W Falk; J Schölmerich; V Gross Journal: Eur J Gastroenterol Hepatol Date: 1999-10 Impact factor: 2.566
Authors: Sunil Singhal; Rainer Wiewrodt; Liliana D Malden; Kunjlata M Amin; Kimberly Matzie; Joseph Friedberg; John C Kucharczuk; Leslie A Litzky; Steven W Johnson; Larry R Kaiser; Steven M Albelda Journal: Clin Cancer Res Date: 2003-08-01 Impact factor: 12.531
Authors: M Hausmann; S Kiessling; S Mestermann; G Webb; T Spöttl; T Andus; J Schölmerich; H Herfarth; K Ray; W Falk; G Rogler Journal: Gastroenterology Date: 2002-06 Impact factor: 22.682
Authors: Ephraim A Ansa-Addo; Jessica Thaxton; Feng Hong; Bill X Wu; Yongliang Zhang; Caroline W Fugle; Alessandra Metelli; Brian Riesenberg; Katelyn Williams; Daniel T Gewirth; Gabriela Chiosis; Bei Liu; Zihai Li Journal: Curr Top Med Chem Date: 2016 Impact factor: 3.295
Authors: Lutz Wolfram; Anne Fischbeck; Isabelle Frey-Wagner; Kacper A Wojtal; Silvia Lang; Michael Fried; Stephan R Vavricka; Martin Hausmann; Gerhard Rogler Journal: PLoS One Date: 2013-10-16 Impact factor: 3.240
Authors: Jesus Cosin-Roger; Marianne R Spalinger; Pedro A Ruiz; Claudia Stanzel; Anne Terhalle; Lutz Wolfram; Hassan Melhem; Kirstin Atrott; Silvia Lang; Isabelle Frey-Wagner; Michael Fried; Michael Scharl; Martin Hausmann; Gerhard Rogler Journal: PLoS One Date: 2018-02-15 Impact factor: 3.240